COURT JAMES JOHN
Known title: DirectorCIK: 0001517804
Associated companies
Transaction History
| AX | ▼ Sell | Open Market | 11,163 | $1.1M | 2/6/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 4,724 | $374K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Other | 2,362 | $187K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Open Market | 16,887 | $1.1M | 11/5/2024 | View on chart |
| AX | ▼ Sell | Other | 3,299 | $229K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,600 | $458K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Other | 1,100 | $76K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,200 | $153K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,934 | $126K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,200 | $95K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 1,466 | $63K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 1,100 | $47K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,600 | $273K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Other | 3,300 | $137K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Open Market | 3,080 | $125K | 9/1/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 5,133 | $214K | 8/31/2022 | View on chart |
| AX | ▼ Sell | Open Market | 1,760 | $74K | 8/2/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,934 | $124K | 8/1/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,934 | $0 | 9/5/2021 | View on chart |
| AX | ▼ Sell | Other | 1,475 | $70K | 9/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Axos Financial Faces Valuation Debate Amid Analyst Support
Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.
Axos Financial Faces Valuation Debate Amid Analyst Support. Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.